However, the above-mentioned different tumoral subtypes, and their variable clinical outcomes, require defining whether breast cancer risk factors, including workplace chemical exposure, may be related to diverse disease phenotypes, particularly concerning hormonal receptor status [9]. This evidence concerns the gene NR4A1 and breast carcinoma.